Hosted on MSN

Tributes pour in as beloved Balm of Gilead CEO, Dr Edmund Arthur tragically passes away

Popular alternative doctor, nutritionist and media personality Dr Edmund Arthur, CEO of Balm of Gilead Clinic, reportedly passed away on December 22, 2025 The tragic news was confirmed in viral ...
FierceBiotech

AbbVie, Gilead gift themselves clinical-stage cancer drugs via licensing deals

AbbVie and Gilead Sciences each used the holiday season to reward their pipelines with a new clinical-stage cancer drug. Zejing Biopharmaceutical unwrapped a $100 million upfront payment from AbbVie ...
The Business Journals

Former Gilead exec who oversaw $20B in drug sales takes global role at autoimmune disease company

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min "I believe we rarely regret the ...
FiercePharma

After scrapped trial, InflaRx could tap partner to revive development of COVID drug in rare skin disorder

Although it looked to be lights out for InflaRx’s C5a antibody vilobelimab in the rare skin disorder pyoderma gangrenosum (PG) last year, the German drugmaker ended 2025 with a glimmer of hope for the ...